Metraipolis › archive › dc_aee8ca577fa3

Impact of the diagnosis-to-treatment interval on the survival of patients with CD5-positive diffuse large B-cell lymphoma — Europe PMC PMID:42033496

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42033496
DOI: 10.1007/s00277-[numero omesso]-0
License (as archived): solo-consultazione
Archived: 2026-11-03T05:35:43.633Z
SHA-256 of the archived text: 9bf428d3ed4f3bd36742ea37e4e8920d279ecaa7c3dfb5a7f4391b6c08957602
Stable URL of this page: https://metraipolis.com/documento/dc_aee8ca577fa3

How to cite

Impact of the diagnosis-to-treatment interval on the survival of patients with CD5-positive diffuse large B-cell lymphoma — Europe PMC PMID:42033496 — Europe PMC (en), https://europepmc.org/article/MED/42033496 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aee8ca577fa3 (Metraipolis archive dc_aee8ca577fa3, sha256 9bf428d3ed4f3bd36742ea37e4e8920d279ecaa7c3dfb5a7f4391b6c08957602)

BibTeX

@misc{dcaee8ca577fa3,
  title = {Impact of the diagnosis-to-treatment interval on the survival of patients with CD5-positive diffuse large B-cell lymphoma — Europe PMC PMID:42033496},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42033496},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aee8ca577fa3; sha256 9bf428d3ed4f3bd36742ea37e4e8920d279ecaa7c3dfb5a7f4391b6c08957602},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42033496. Agents can read the archived copy with the MCP tool read_document.